Design and synthesis of 6-C-alkyl-DMDP type nanomolar inhibitors of β-galactosidase and β-glucosidase based on broussonetine S and related derivatives
-
Published:2024-09
Issue:
Volume:275
Page:116570
-
ISSN:0223-5234
-
Container-title:European Journal of Medicinal Chemistry
-
language:en
-
Short-container-title:European Journal of Medicinal Chemistry
Author:
Gao Feng-Teng, Wu Qing-Kun, Zhang Ming, Shimadate Yuna, Qian Gong, Song Ying-Ying, Kato Atsushi, Li Yi-Xian, Jia Yue-Mei, Fleet George W.J., Yu Chu-YiORCID
Reference31 articles.
1. Studies on the constituents of Broussonetia species VIII. Four new pyrrolidine alkaloids, broussonetines R, S, T, and V and a new pyrroline alkaloid, broussonetine U, from Broussonetia kazinoki SIEB;Tsukamoto;Chem. Pharm. Bull.,2001 2. Studies on the constituents of Broussonetia species. VII. Four new pyrrolidine alkaloids, broussonetines M, O, P, and Q, as inhibitors of glycosidase, from Broussonetia kazinoki SIEB;Shibano;Chem. Pharm. Bull. (Tokyo),2000 3. Studies on the constituents of Broussonetia species. V. Two new pyrrolidine alkaloids, broussonetines K and L, as inhibitors of glycosidase, from Broussonetia kazinoki SIEB;Shibano;Chem. Pharm. Bull. (Tokyo),1999 4. Studies on the constituents of Broussonetia species. IV. Two new pyrrolidinyl piperidine alkaloids, broussonetines I and J, from Broussonetia kazinoki SIEB;Shibano;Chem. Pharm. Bull. (Tokyo),1998 5. Studies on the constituents of Broussonetia species. I. Two new pyrrolidine alkaloids, broussonetines C and D, as β-galactosidase and β-mannosidase inhibitors from Broussonetia kazinoki SIEB;Shibano;Chem. Pharm. Bull. (Tokyo),1997
|
|